Skip to main content
Top
Published in: Digestive Diseases and Sciences 10/2007

01-10-2007 | Original Paper

Helicobacter pylori Infection and Severity of Reflux-Induced Esophageal Disease in a Cohort of Patients with Columnar-Lined Esophagus

Authors: James R. Ramus, Piers A. C. Gatenby, Christine P. J. Caygill, Anthony Watson

Published in: Digestive Diseases and Sciences | Issue 10/2007

Login to get access

Abstract

The relationship between Helicobacter pylori infection and reflux-induced esophageal diseased is controversial. We examined esophageal disease severity in patients with columnar-lined esophagus and compared results between patients with and without Helicobacter pylori infection. Medical records of 1000 patients diagnosed with columnar-lined esophagus were examined. Endoscopic and histological findings of reflux-induced esophageal disease were compared between H. pylori-positive and H. pylori-negative patients. Four hundred twenty-nine patients (42.9%) showed evidence of H. pylori status, of whom 239 (55.7%) were positive and 190 (44.3%) negative. There were no significant differences in length of columnar-lined segment (= 0.305), frequency of associated esophagitis (= 0.583), or presence of gastroduodenal inflammation (= 0.335, = 0.131) between the two groups. Histological grade of esophageal disease severity was similar between them, with no statistically significant differences (= 0.231).
We conclude that in patients with established columnar-lined esophagus, there appears to be no difference in severity of reflux-induced esophageal disease between those with and those without H. pylori infection.
Literature
1.
go back to reference Lee JM, O’Morain CA (1998) Different management for Helicobacter pylori positive and negative patients with gastro-oesophageal reflux disease? Gut 43(Suppl 1):S14–S20PubMedCrossRef Lee JM, O’Morain CA (1998) Different management for Helicobacter pylori positive and negative patients with gastro-oesophageal reflux disease? Gut 43(Suppl 1):S14–S20PubMedCrossRef
2.
go back to reference Fink SM et al. (1984) The association of histologic gastritis with gastroesophageal reflux and delayed gastric emptying. J Clin Gastroenterol 6:301–309PubMed Fink SM et al. (1984) The association of histologic gastritis with gastroesophageal reflux and delayed gastric emptying. J Clin Gastroenterol 6:301–309PubMed
3.
go back to reference Vicari J, Falk GW, Richter JE (1997) Helicobacter pylori and acid peptic disorders of the esophagus: is it conceivable? Am J Gastroenterol 92:1097–1102PubMed Vicari J, Falk GW, Richter JE (1997) Helicobacter pylori and acid peptic disorders of the esophagus: is it conceivable? Am J Gastroenterol 92:1097–1102PubMed
4.
go back to reference Boyd EJ (1996) The prevalence of esophagitis in patients with duodenal ulcer or ulcer-like dyspepsia. Am J Gastroenterol 91:1539–1543PubMed Boyd EJ (1996) The prevalence of esophagitis in patients with duodenal ulcer or ulcer-like dyspepsia. Am J Gastroenterol 91:1539–1543PubMed
5.
go back to reference Labenz J, Malfertheiner P (1997) Helicobacter pylori in gastro-oesophageal reflux disease: Causal agent, independent or protective factor? Gut 41:277–280PubMedCrossRef Labenz J, Malfertheiner P (1997) Helicobacter pylori in gastro-oesophageal reflux disease: Causal agent, independent or protective factor? Gut 41:277–280PubMedCrossRef
6.
go back to reference Hirschl AM, Schulze K, Hentsche E (1989) Serological, microbiological and clinical results of a 43 months follow-up after successful eradication of H. pylori in duodenal ulcer disease. Am J Gastroenterol 89:1374 Hirschl AM, Schulze K, Hentsche E (1989) Serological, microbiological and clinical results of a 43 months follow-up after successful eradication of H. pylori in duodenal ulcer disease. Am J Gastroenterol 89:1374
7.
go back to reference Rauws EA, Tytgat GN (1990) Cure of duodenal ulcer associated with eradication of Helicobacter pylori. Lancet 335:1233–1235PubMedCrossRef Rauws EA, Tytgat GN (1990) Cure of duodenal ulcer associated with eradication of Helicobacter pylori. Lancet 335:1233–1235PubMedCrossRef
8.
go back to reference Parsonnet J, et al. (1991) Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 325:1127–1131PubMedCrossRef Parsonnet J, et al. (1991) Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 325:1127–1131PubMedCrossRef
9.
go back to reference Axon A, Forman D (1997) Helicobacter gastroduodenitis: a serious infectious disease. BMJ 314:1430–431PubMed Axon A, Forman D (1997) Helicobacter gastroduodenitis: a serious infectious disease. BMJ 314:1430–431PubMed
10.
go back to reference Nomura A, Stemmermann GN, Chyou PH, Perez-Perez GI, Blaser MJ (1994) Helicobacter pylori infection and the risk for duodenal and gastric ulceration. Ann Intern Med 120:977–981PubMed Nomura A, Stemmermann GN, Chyou PH, Perez-Perez GI, Blaser MJ (1994) Helicobacter pylori infection and the risk for duodenal and gastric ulceration. Ann Intern Med 120:977–981PubMed
11.
go back to reference Uemura N, et al. (2001) Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 345:784–789PubMedCrossRef Uemura N, et al. (2001) Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 345:784–789PubMedCrossRef
12.
go back to reference Richter JE (2001) H pylori: the bug is not all bad. Gut 49:319–320PubMed Richter JE (2001) H pylori: the bug is not all bad. Gut 49:319–320PubMed
13.
go back to reference Blaser MJ (1999) Hypothesis: the changing relationships of Helicobacter pylori and humans: implications for health and disease. J Infect Dis 179:1523–1530PubMedCrossRef Blaser MJ (1999) Hypothesis: the changing relationships of Helicobacter pylori and humans: implications for health and disease. J Infect Dis 179:1523–1530PubMedCrossRef
14.
go back to reference Sehiguchi T, Shirota T, Horikoshi T (1996) Helicobacter pylori infection and severity of reflux oesophagitis. Gastroenterology 110:A755 Sehiguchi T, Shirota T, Horikoshi T (1996) Helicobacter pylori infection and severity of reflux oesophagitis. Gastroenterology 110:A755
15.
go back to reference Grebenev AL (1994) Helicobacter pylori (Hp) and reflux oesophagitis. Gastroenterology 89:A1372 Grebenev AL (1994) Helicobacter pylori (Hp) and reflux oesophagitis. Gastroenterology 89:A1372
16.
go back to reference Labenz J, et al. (1997) Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology 112:1442–1447PubMedCrossRef Labenz J, et al. (1997) Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology 112:1442–1447PubMedCrossRef
17.
go back to reference Levi S, et al. (1989) Campylobacter pylori and duodenal ulcers: the gastrin link. Lancet 1:1167–1168PubMedCrossRef Levi S, et al. (1989) Campylobacter pylori and duodenal ulcers: the gastrin link. Lancet 1:1167–1168PubMedCrossRef
18.
go back to reference Smith JT, et al. (1990) Inappropriate hypergastrinaemia in asymptomatic healthy subjects infected with Helicobacter pylori. Gut 31:522–525PubMed Smith JT, et al. (1990) Inappropriate hypergastrinaemia in asymptomatic healthy subjects infected with Helicobacter pylori. Gut 31:522–525PubMed
19.
go back to reference el Omar EM, et al. (1995) Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease. Gastroenterology 109:681–691PubMedCrossRef el Omar EM, et al. (1995) Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease. Gastroenterology 109:681–691PubMedCrossRef
20.
go back to reference Sharma VK, Demian SE, Taillon D, Vasudeva R, Howden CW (1999) Examination of tissue distribution of Helicobacter pylori within columnar-lined esophagus. Dig Dis Sci 44:1165–1168PubMedCrossRef Sharma VK, Demian SE, Taillon D, Vasudeva R, Howden CW (1999) Examination of tissue distribution of Helicobacter pylori within columnar-lined esophagus. Dig Dis Sci 44:1165–1168PubMedCrossRef
21.
go back to reference Caygill CP, et al. (2002) Lifestyle factors and Barrett’s esophagus. Am J Gastroenterol 97:1328–1331PubMedCrossRef Caygill CP, et al. (2002) Lifestyle factors and Barrett’s esophagus. Am J Gastroenterol 97:1328–1331PubMedCrossRef
22.
go back to reference Rugge M, et al. (2001) The phenotype of gastric mucosa coexisting with Barrett’s oesophagus. J Clin Pathol 54:456–460PubMedCrossRef Rugge M, et al. (2001) The phenotype of gastric mucosa coexisting with Barrett’s oesophagus. J Clin Pathol 54:456–460PubMedCrossRef
23.
go back to reference Oberg S, et al. (1999) Helicobacter pylori is not associated with the manifestations of gastroesophageal reflux disease. Arch Surg 134:722–726PubMedCrossRef Oberg S, et al. (1999) Helicobacter pylori is not associated with the manifestations of gastroesophageal reflux disease. Arch Surg 134:722–726PubMedCrossRef
24.
go back to reference Newton M, Bryan R, Burnham WR, Kamm MA (1997) Evaluation of Helicobacter pylori in reflux oesophagitis and Barrett’s oesophagus. Gut 40:9–13PubMed Newton M, Bryan R, Burnham WR, Kamm MA (1997) Evaluation of Helicobacter pylori in reflux oesophagitis and Barrett’s oesophagus. Gut 40:9–13PubMed
25.
go back to reference Henihan RD, et al. (1998) Barrett’s esophagus and the presence of Helicobacter pylori. Am J Gastroenterol 93:542–546PubMedCrossRef Henihan RD, et al. (1998) Barrett’s esophagus and the presence of Helicobacter pylori. Am J Gastroenterol 93:542–546PubMedCrossRef
26.
go back to reference Loffeld RJ, Ten Tije BJ, Arends JW (1992) Prevalence and significance of Helicobacter pylori in patients with Barrett’s esophagus. Am J Gastroenterol 87:1598–1600PubMed Loffeld RJ, Ten Tije BJ, Arends JW (1992) Prevalence and significance of Helicobacter pylori in patients with Barrett’s esophagus. Am J Gastroenterol 87:1598–1600PubMed
27.
go back to reference Hackelsberger A, et al. (1998) The prevalence of Helicobacter pylori gastritis in patients with reflux oesophagitis: a case-control study. Eur J Gastroenterol Hepatol 10:465–468PubMedCrossRef Hackelsberger A, et al. (1998) The prevalence of Helicobacter pylori gastritis in patients with reflux oesophagitis: a case-control study. Eur J Gastroenterol Hepatol 10:465–468PubMedCrossRef
28.
go back to reference Grimley CE, Holder RL, Loft DE, et al. (1999) Helicobacter pylori-associated antibodies in patients with duodenal ulcer, gastric and oesophageal adenocarcinoma. Eur J Gastro Hepatol 11:503–509CrossRef Grimley CE, Holder RL, Loft DE, et al. (1999) Helicobacter pylori-associated antibodies in patients with duodenal ulcer, gastric and oesophageal adenocarcinoma. Eur J Gastro Hepatol 11:503–509CrossRef
29.
go back to reference Verdu EF, et al. (1995) Effect of Helicobacter pylori status on intragastric pH during treatment with omeprazole. Gut 36:539–543PubMed Verdu EF, et al. (1995) Effect of Helicobacter pylori status on intragastric pH during treatment with omeprazole. Gut 36:539–543PubMed
30.
go back to reference Labenz J, et al. (1996) Helicobacter pylori augments the pH-increasing effect of omeprazole in patients with duodenal ulcer. Gastroenterology 110:725–732PubMedCrossRef Labenz J, et al. (1996) Helicobacter pylori augments the pH-increasing effect of omeprazole in patients with duodenal ulcer. Gastroenterology 110:725–732PubMedCrossRef
31.
go back to reference Kuipers EJ, et al. (1996) Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication. N Engl J Med 334:1018–1022PubMedCrossRef Kuipers EJ, et al. (1996) Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication. N Engl J Med 334:1018–1022PubMedCrossRef
Metadata
Title
Helicobacter pylori Infection and Severity of Reflux-Induced Esophageal Disease in a Cohort of Patients with Columnar-Lined Esophagus
Authors
James R. Ramus
Piers A. C. Gatenby
Christine P. J. Caygill
Anthony Watson
Publication date
01-10-2007
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 10/2007
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-006-9706-z

Other articles of this Issue 10/2007

Digestive Diseases and Sciences 10/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine